Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 258

1.

Enhanced intestinal permeability and oral bioavailability of enalapril maleate upon complexation with the cationic polymethacrylate Eudragit E100.

Ramírez-Rigo MV, Olivera ME, Rubio M, Manzo RH.

Eur J Pharm Sci. 2014 May 13;55:1-11. doi: 10.1016/j.ejps.2014.01.001. Epub 2014 Jan 20.

PMID:
24456933
2.

Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.

Yun F, Kang A, Shan J, Zhao X, Bi X, Li J, Di L.

Int J Pharm. 2014 Apr 25;465(1-2):436-43. doi: 10.1016/j.ijpharm.2014.02.040. Epub 2014 Feb 25.

PMID:
24576810
3.

A novel pulsatile drug delivery system based on the physiochemical reaction between acrylic copolymer and organic acid: in vitro and in vivo evaluation.

Zhang Z, Qi X, Li X, Xing J, Zhu X, Wu Z.

Int J Pharm. 2014 Feb 28;462(1-2):66-73. doi: 10.1016/j.ijpharm.2013.12.026. Epub 2013 Dec 22.

PMID:
24368107
4.

Interaction between a cationic polymethacrylate (Eudragit E100) and anionic drugs.

Quinteros DA, Rigo VR, Kairuz AF, Olivera ME, Manzo RH, Allemandi DA.

Eur J Pharm Sci. 2008 Jan;33(1):72-9. Epub 2007 Oct 23.

PMID:
18060747
5.

Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.

Freag MS, Elnaggar YS, Abdallah OY.

Int J Pharm. 2013 Sep 15;454(1):462-71. doi: 10.1016/j.ijpharm.2013.06.039. Epub 2013 Jul 3.

PMID:
23830765
6.

Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.

Zhaojie M, Ming Z, Shengnan W, Xiaojia B, Hatch GM, Jingkai G, Li C.

Int J Pharm. 2014 Jun 5;467(1-2):50-9. doi: 10.1016/j.ijpharm.2014.03.017. Epub 2014 Mar 5.

PMID:
24607213
7.

Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.

Onoue S, Kojo Y, Aoki Y, Kawabata Y, Yamauchi Y, Yamada S.

Drug Metab Pharmacokinet. 2012;27(4):379-87. Epub 2012 Jan 13.

8.

Transdermal therapeutic system of enalapril maleate using piperidine as penetration enhancer.

Aqil M, Bhavna, Chowdhary I, Sultana Y, Talegaonkar S, Ahmad FJ, Ali MM.

Curr Drug Deliv. 2008 Apr;5(2):148-52.

PMID:
18393818
9.

Stability and in vitro release profile of enalapril maleate from different commercially available tablets: possible therapeutic implications.

Lima DM, dos Santos LD, Lima EM.

J Pharm Biomed Anal. 2008 Aug 5;47(4-5):934-7. doi: 10.1016/j.jpba.2008.02.030. Epub 2008 Mar 4.

PMID:
18472382
10.

Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan.

Chella N, Daravath B, Kumar D, Tadikonda RR.

Eur J Drug Metab Pharmacokinet. 2016 Oct;41(5):517-26. doi: 10.1007/s13318-015-0290-5.

PMID:
26156887
11.

Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery.

Kumar BS, Saraswathi R, Kumar KV, Jha SK, Venkates DP, Dhanaraj SA.

Drug Deliv. 2014 May;21(3):173-84. doi: 10.3109/10717544.2013.840690. Epub 2013 Oct 9.

PMID:
24102185
12.

Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR.

Sahoo J, Murthy PN, Biswal S, Manik.

AAPS PharmSciTech. 2009;10(1):27-33. doi: 10.1208/s12249-008-9175-0. Epub 2009 Jan 15.

13.

The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membrane.

Dahan A, Beig A, Ioffe-Dahan V, Agbaria R, Miller JM.

AAPS J. 2013 Apr;15(2):347-53. doi: 10.1208/s12248-012-9445-3. Epub 2012 Dec 15.

14.

Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.

Zhao X, Shan C, Zu Y, Zhang Y, Wang W, Wang K, Sui X, Li R.

Int J Pharm. 2013 Sep 15;454(1):278-84. doi: 10.1016/j.ijpharm.2013.06.051. Epub 2013 Jul 3.

PMID:
23830939
15.

Preparation and characterization of salt forms of enalapril.

Kumar L, Amin A, Bansal AK.

Pharm Dev Technol. 2008;13(5):345-57. doi: 10.1080/10837450802244686 .

PMID:
18720234
16.

Application of carrier and plasticizer to improve the dissolution and bioavailability of poorly water-soluble baicalein by hot melt extrusion.

Zhang Y, Luo R, Chen Y, Ke X, Hu D, Han M.

AAPS PharmSciTech. 2014 Jun;15(3):560-8. doi: 10.1208/s12249-013-0071-x. Epub 2014 Feb 26.

17.

Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.

Nielsen LH, Gordon S, Holm R, Selen A, Rades T, Müllertz A.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):942-51. doi: 10.1016/j.ejpb.2013.09.002. Epub 2013 Sep 27.

PMID:
24075980
18.

Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.

Wegiel LA, Mauer LJ, Edgar KJ, Taylor LS.

J Pharm Sci. 2013 Jan;102(1):171-84. doi: 10.1002/jps.23358. Epub 2012 Nov 6.

PMID:
23132686
19.
20.

Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability.

Benival DM, Devarajan PV.

Int J Pharm. 2012 Feb 28;423(2):554-61. doi: 10.1016/j.ijpharm.2011.11.035. Epub 2011 Dec 2.

PMID:
22155412

Supplemental Content

Support Center